Skip to main content
for

Dr. Lindsay F. Schwartz: Faculty Experts

Not seeing the results that match your search? FILTER BY CATEGORY AND FIELD

Dr. Lindsay F. Schwartz

Northwestern University Feinberg School of Medicine

Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation)

About

Areas of Focus

  • Childhood, adolescent and young adult cancer survivorship
  • Adolescent and young adult oncology
  • Lymphoma
  • Oncofertility

Work/Research

  • Impact of health behaviors and psychosocial factors on long-term health outcomes of childhood, adolescent and young adult cancer survivors
  • Clinical outcomes of young patients with rare types of non-Hodgkin lymphoma
  • Long-term fertility issues in young patients receiving gonadotoxic therapies

Career

Dr. Lindsay Schwartz is a pediatric oncologist and physician scientist at Ann & Robert H. Lurie Children's Hospital of Chicago. She received her medical degree from University of Illinois College of Medicine in 2015. She then completed her residency in pediatrics at the University of California, Los Angeles (UCLA) in 2018 and returned to Chicago to complete her pediatric hematology/oncology fellowship training at the University of Chicago in 2022. During her fellowship, she obtained a master of science in public health sciences, also from the University of Chicago. She joined the Division of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation at Lurie Children's Hospital in 2025.

Dr. Schwartz’s clinical interests include caring for children, teenagers and young adults with leukemia, lymphoma, lymphoproliferative disorders and histiocytic neoplasms. She also treats long-term survivors of all childhood, adolescent and young adult cancers.

Dr. Schwartz’s research investigates the impact of health behaviors and psychosocial factors on long-term health outcomes of childhood, adolescent and young adult cancer survivors. She also evaluates clinical outcomes of young patients with rare types of non-Hodgkin lymphoma, who are often ineligible for clinical trials. Lastly, she studies long-term fertility issues that young patients receiving gonadotoxic therapies may face as cancer survivors.

Dr. Schwartz is a member of the Children’s Oncology Group (COG) Non-Hodgkin Lymphoma and Outcomes/Survivorship committees, serving on the COG Long-Term Follow Up Guidelines Taskforce. Her research has received grants from the National Cancer Institute (NCI) and United States Department of Defense (DOD), and Dr. Schwartz is the prior recipient of the 2021 International Society of Pediatric Oncology (SIOP) Young Investigator Award and the 2024 American Society of Pediatric Hematology/Oncology (ASPHO) Young Investigator Award.